What Happens When Meth Use Stops

When someone who has been using methamphetamine regularly stops or significantly reduces use, withdrawal symptoms typically begin within 24 hours. These symptoms reflect the brain and body adjusting after a period of sustained stimulant exposure — a process that takes time and can vary significantly depending on how much someone was using, for how long, and whether other substances were involved.

Methamphetamine withdrawal is a recognized clinical syndrome. The DSM-5 describes a stimulant withdrawal syndrome that includes dysphoric mood and physiological changes following cessation or reduction of prolonged heavy use. The symptoms are real, and for many people they are distressing enough to drive a return to use. Understanding what withdrawal involves — and what appropriate support looks like — can make a meaningful difference in how this period goes.

Symptoms of Meth Withdrawal

The core symptoms of methamphetamine withdrawal include:

  • Dysphoria and depression: A significant low mood — sometimes severe — as the brain’s dopamine system adjusts to the absence of stimulant input. This is one of the most clinically important features of meth withdrawal.
  • Fatigue and hypersomnia: Profound tiredness is common after the stimulant effect ends. Many people sleep for extended periods during the early days of withdrawal.
  • Increased appetite: Meth suppresses appetite; when use stops, appetite typically returns, often intensely.
  • Anxiety and agitation: Restlessness, irritability, and anxiety are common, particularly in the early phase.
  • Cognitive difficulty: Concentration and memory can be significantly impaired during withdrawal and for some weeks afterward.
  • Vivid and unpleasant dreams: Disturbing dreams are a frequently reported feature of the withdrawal period.
  • Psychomotor changes: Slowing or agitation in physical movement and speech.
  • Psychotic symptoms: In some people, withdrawal is accompanied by paranoia, hallucinations, or disorganized thinking. This requires clinical assessment and may indicate a need for more intensive care.

Depression during meth withdrawal can be severe, and in some cases includes suicidal ideation. This is a medical risk that requires clinical attention. If suicidal thoughts occur during withdrawal, this is a reason to seek immediate support — crisis support before outpatient treatment planning. The 988 Suicide and Crisis Lifeline (call or text 988) is available around the clock.

Timeline and the Protracted Recovery Period

Meth withdrawal does not follow a single uniform timeline. A general pattern includes an acute crash phase in the first one to three days, an acute withdrawal phase lasting approximately one to two weeks, and an extended recovery period that can continue for weeks or months afterward. During this extended period, mood instability, anhedonia (difficulty experiencing pleasure), sleep disruption, and cognitive difficulties often persist at lower intensity.

This extended recovery — sometimes called post-acute withdrawal syndrome (PAWS) — represents ongoing risk for returning to use. Cravings, persistent low mood, and difficulty functioning can all make the post-acute period difficult, even after the acute symptoms have resolved. Structured support during this period is a clinically significant component of meth recovery.

Medical Considerations

The clinical risk profile of methamphetamine withdrawal is different from alcohol or benzodiazepine withdrawal — meth withdrawal does not routinely involve the same risk of seizures or life-threatening autonomic instability. However, meth withdrawal carries its own serious risks, and the appropriate level of care depends on individual clinical assessment.

Severe depression with suicidal ideation during withdrawal may require medical attention or a level of care beyond standard outpatient treatment. Psychotic symptoms during withdrawal also require clinical evaluation. In individuals with a seizure disorder, polysubstance use, or other complicating medical factors, the withdrawal picture may be more complex.

A clinical assessment that accounts for these individual factors determines what level of monitoring and support is appropriate — ranging from outpatient treatment with regular clinical contact and psychiatric support where needed, to medical stabilization before outpatient treatment begins. The appropriate setting is not determined by a general assumption that meth withdrawal is or is not manageable outpatient; it is determined by what the individual assessment indicates.

Meth Withdrawal in LGBTQ+ Contexts

Crystal methamphetamine is used at elevated rates among gay, bisexual, and other men who have sex with men, often in chemsex contexts where meth is used to enhance sexual experience or reduce inhibition. For people coming out of heavy use in these contexts, withdrawal involves both the clinical adjustment and a social adjustment: changing patterns that may have been deeply integrated into community, sex, and connection.

An LGBTQ+-affirming clinical environment is one where this context — including the role meth has played in social and sexual life — does not need to be explained before getting to the clinical work.

What Comes Next

There are currently no FDA-approved medications specifically for methamphetamine withdrawal or addiction, though clinical research is ongoing. Evidence-based approaches for meth recovery focus on behavioral treatments: cognitive behavioral therapy, contingency management, and structured clinical support through the protracted recovery period.

For people who use meth, the withdrawal period is the beginning of recovery, not the end of the work. Outpatient treatment — at PHP, IOP, or standard outpatient level depending on clinical assessment — provides structure, ongoing clinical monitoring, and evidence-based behavioral treatment during the extended period when mood and cognitive symptoms persist.

Our crystal meth addiction treatment page describes how treatment works at Inspire Recovery. Our chemsex addiction treatment page addresses the specific context of meth use in sexual and social settings. If you are approaching stopping meth and want to understand what clinical support is available, our admissions team can listen and help.

561-725-9877 | Verify Your Insurance

Sources: SAMHSA TIP 45: Detoxification and Substance Abuse Treatment (SAMHSA, 2015) | SAMHSA TIP 33: Treatment for Stimulant Use Disorders, Updated 2021 (Chapter 3: Stimulant Intoxication and Withdrawal) | ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023)